New Wave Health Tirzepatide Review: Care, Cost and Terms

New Wave Health publishes a specific compounded tirzepatide treatment alongside semaglutide and other programs. Its site describes secure intake, provider review, medication delivery and ongoing contact. The useful purchasing question is which offer applies to tirzepatide and how the recurring contract fits the flexibility suggested by its marketing.¹

This review examines published information checked in October 2026. We did not buy medication, submit a medical intake or receive treatment. Descriptions of clinical support, delivery and product performance are the provider’s claims unless a separate source is identified.

What the advertised price actually covers

The homepage advertises plans from $139 per month, confirmed after provider review. This is a broad plan headline rather than a verified all-dose tirzepatide amount. Separate product pages and medication descriptions should not be combined into a single universal price. Request the actual product, milligrams, total quantity, period of supply, payment due now and next renewal rate.³

Use a written quote as the comparison unit: product, prescribed milligrams, amount supplied, days of treatment, total due and next payment. A four-week shipment and a calendar-month subscription can produce different refill dates. A monthly equivalent of a longer prepaid plan also says nothing by itself about whether unused treatment can be refunded. Keep a copy of the selected offer and the terms presented before payment.

Clinical care and follow-up

The platform describes independent licensed clinicians and pharmacy partners. Its homepage expressly notes that compounded semaglutide and tirzepatide are not FDA-approved and are not the branded medicines. That distinction is useful. It does not independently establish the identity, licensing or quality of the pharmacy assigned to your order, nor whether the clinician is authorized in your consultation location.¹

Ask how symptoms are handled between planned reviews and whether the responding person can make clinical decisions. Account support, a prescription review and an ongoing medical appointment are different services. If your clinician recommends a pause or a different medication, establish how the clinical decision reaches the dispensing team and billing system. That coordination matters as much as a promise of convenient ordering.

Cancellation and refunds

The tirzepatide FAQ requires 30 days’ cancellation notice before the next billing cycle. The terms instead permit disabling auto-refill at least 48 hours before the monthly processing date and describe recurring charges every 30 days. Treat this as an unresolved conflict in the public offer. A shorter contractual sentence should not silently erase the longer product condition. Initial prescription cancellation is a separate rule in the terms: a request within 24 hours is conditional on the provider network not yet receiving the order. This does not create a guaranteed first-day cancellation window after clinical processing has begun.¹²

Record the next processing date rather than estimating it from the day a parcel arrives. Ask whether cancellation stops only a future renewal or also a prescription already under review. A request to stop treatment does not automatically establish a refund of completed medical or pharmacy work. Save the written acknowledgment and ask where an unresolved billing error should be reported.

The product details that change the decision

The program describes flat pricing, provider-directed adjustments, portal messaging and check-ins. Ask whether any clinical pause also pauses billing and whether a prescription refill can be stopped after it has been reviewed. Consultation services and medication processing are distinct stages, so a canceled renewal does not necessarily mean an already approved order is refundable. Obtain the selected plan’s written answer before submitting payment.¹

Pharmacy, formulation and prescribing boundaries

Before accepting a prescription, obtain the actual dispensing pharmacy’s legal name, contact details and authorization to supply your state. If a provider lists pharmacy partners, ask which one is assigned to this order. A website’s description of licensing or certification is not the same as our independent verification of that pharmacy or its current authorization.

If compounded medication is proposed, the distinction from an approved medicine remains important. FDA says compounded GLP-1 products are not FDA-approved and do not undergo its premarket review for safety, effectiveness and quality. FDA recommends compounded drugs only when the patient’s medical needs cannot be met by an approved product. Sharing an ingredient name or displaying a branded-trial result does not establish that an exact compounded formulation performs identically.⁴

Request the prescribed dose in milligrams, concentration, administration instructions, storage requirements and beyond-use date for the actual dispensed product. Do not borrow syringe-unit instructions from another service or assume a tablet and injection are equivalent. If the label or shipment is unclear, ask the prescriber or dispenser before use. FDA has documented dosing errors and refrigeration concerns with compounded GLP-1 medicines.⁴

Clinical suitability is a separate decision from affordability. The approved Zepbound label includes a boxed warning concerning thyroid C-cell tumors seen in rodents and contraindications including a personal or family history of medullary thyroid carcinoma or MEN2. Other medicines, pregnancy plans, gastrointestinal symptoms and prior treatment need individual review. A short online screening form is not a reason to skip the full medication history.⁵

Who should pay particular attention to these terms

The $139 homepage figure is useful only after the proposed prescription is identified. A buyer comparing that number with a named tirzepatide quote elsewhere could be comparing different molecules, quantities or commitment lengths. Ask for a single plan document connecting the public offer to the selected prescription and the policy governing renewal. If treatment changes, request a revised quote rather than assuming the original amount follows every product. Our Gide review illustrates similar price-to-product ambiguity, while Robinhood’s review explains why a conflicting notice period matters. New Wave’s explicit compounded-product disclaimer helps identify the regulatory category; it does not settle the final cost or exit conditions.

How we would compare New Wave Health

New Wave provides a real named pathway with enough detail to compare care and financial questions. Its strengths are the explicit compounded-product distinction and the described continuing clinical access. The deciding uncertainties are the final tirzepatide quote, patient-specific state and pharmacy availability, and the inconsistent renewal notice. Its branded-trial summaries are not independently measured results for its own compounded product.

Compare the final written offer with other provider reviews and different care arrangements. For an approved-product alternative, the Zepbound cost and savings guide separates medication access from the cost of a clinical program. Make the comparison at the same prescribed dose and payment commitment, with the follow-up and exit conditions visible.

To compare which written renewal rules apply to the selected online plan, see FeelGood Meds and MultiMedRx.